GSK taps TrialScope for clinical trial transparency

October 9, 2018

As seen on Outsourcing-Pharma.com - Posted Oct. 8, 2018 - Original Article

 By Melissa Fassbender | GlaxoSmithKline has selected TrialScope to facilitate clinical trial disclosure and transparency – as the benefits of patient centricity are paramount, and the risks of poor compliance magnified, says VP.


Continued on Outsourcing Pharma

Previous Article
Q&A: Clinical Trial Transparency
Q&A: Clinical Trial Transparency

Next Article
Five benefits to developing a global transparency policy (MedCity News)
Five benefits to developing a global transparency policy (MedCity News)